Endocrine Disruptors in the Workplace, Hair Spray, Folate Supplementation, and Risk of Hypospadias: Case–Control Study
2009

Risk Factors for Hypospadias in Children

Sample size: 961 publication 10 minutes Evidence: high

Author Information

Author(s): Ormond Gillian, Nieuwenhuijsen Mark J., Nelson Paul, Toledano Mireille B., Iszatt Nina, Geneletti Sara, Elliott Paul

Primary Institution: Department of Epidemiology and Public Health, Imperial College London

Hypothesis

Is there an association between maternal occupational exposure to endocrine disruptors, folate supplementation during pregnancy, and the risk of hypospadias?

Conclusion

The study found increased risks of hypospadias associated with maternal exposure to hair spray and phthalates, while folate supplementation during early pregnancy may be protective.

Supporting Evidence

  • Occupational exposure to hair spray was associated with a 2.39 times increased risk of hypospadias.
  • Phthalate exposure was linked to a 3.12 times increased risk of hypospadias.
  • Folate supplementation during the first 3 months of pregnancy was associated with a 36% reduction in risk of hypospadias.
  • Vegetarianism was not found to be associated with hypospadias risk.

Takeaway

Moms who worked with certain hair products or chemicals might have a higher chance of having baby boys with a condition called hypospadias, but taking folic acid during pregnancy could help protect against it.

Methodology

A case-control study involving 471 hypospadias cases and 490 controls, with data collected through telephone interviews and a job exposure matrix.

Potential Biases

Possible selection bias due to the convoluted process of contacting control participants.

Limitations

Low response rate from control participants and potential recall bias.

Participant Demographics

Mothers of children born in southeast England between January 1997 and September 1998.

Statistical Information

P-Value

0.001

Confidence Interval

95% CI, 1.40–4.17 for hair spray exposure; 95% CI, 0.44–0.93 for folate supplementation.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1289/ehp.11933

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication